Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat

International Review of Neurobiology

Volumn 82, Issue , 2007, Pages 149-169

  Amantea, Diana ^a   Russo, Rossella ^a   Gliozzi, Micaela ^b   Fratto, Vincenza ^b   Berliocchi, Laura ^a,c   Bagetta, G ^a   Bernardi, G ^c   Corasaniti, M Tiziana ^b,c  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; GELATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MATRIX METALLOPROTEINASE;

ANIMAL; BIOSYNTHESIS; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; ENZYMOLOGY; FLUOROMETRY; GENETICS; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; REPERFUSION INJURY; REVIEW; UPREGULATION; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CASPASE 1; FLUOROMETRY; GELATIN; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; RATS; RATS, WISTAR; REPERFUSION INJURY; UP-REGULATION;

EID: 34547379395     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)82008-3     Document Type: Review

References (72)

1. Akita K., Ohtsuki T., Nukada Y., Tanimoto T., Namba M., Okura T., Takakura-Yamamoto R., Torigoe K., Gu Y., Su M.S., Fujii M., Satoh-Itoh M., et al. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J. Biol. Chem. 272 (1997) 26595-26603
2. Asahi M., Asahi K., Jung J.C., del Zoppo G.J., Fini M.E., and Lo E.H. Role for matrix metalloproteinase 9 after focal cerebral ischemia: Effects of gene knockdown and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20 (2000) 1681-1689
3. Asahi M., Hoshimaru M., Uemura Y., Tokime T., Kojima M., Ohtsuka T., Matsuura N., Aoki T., Shibahara K., and Kikuchi H. Expression of interleukin-1 beta converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery. J. Cereb. Blood Flow Metab. 17 (1997) 11-18
4. Asahi M., Sumii T., Fini M.E., Itohara S., and Lo E.H. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport 12 (2001) 3003-3007
5. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
6. Benchoua A., Guegan C., Couriaud C., Hosseini H., Sampaio N., Morin D., and Onteniente B. Specific caspase pathways are activated in the two stages of cerebral infarction. J. Neurosci. 21 (2001) 7127-7134
7. Black R.A., Kronheim S.R., Cantrell M., Deeley M.C., March C.J., Prickett K.S., Wignall J., Conlon P.J., Cosman D., Hopp T.P., and Mochizuki D.Y. Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 263 (1988) 9437-9442
8. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., and Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85 (1996) 683-693
9. Buttini M., Sauter A., and Boddeke H. Induction of interleukin-1beta mRNA after focal ischemia in the rat. Mol. Brain Res. 23 (1994) 126-134
10. Castellanos M., Leira R., Serena J., Pumar J.M., Lizasoain I., Castillo J., and Davalos A. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 34 (2003) 40-46
11. Chen Z.L., Indyk J.A., and Strickland S. The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol. Biol. Cell 14 (2003) 2665-2676
12. Copin J.-C., Goodyear M.C., Gidday J.M., Shah A.R., Gascon E., Dayer A., Morel D.M., and Gasche Y. Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice. Eur. J. Neurosci. 22 (2005) 1597-1608
13. Corasaniti M.T., Turano P., Bilotta A., Malorni W., Stringaro A.R., Nisticò R., Finazzi-Agrò A., and Bagetta G. Evidence that increases of mitochondrial immunoreactive IL-1β by HIV-1 gp120 implicate in situ cleavage of pro-IL-1β in the neocortex of rat. J. Neurochem. 78 (2001) 611-618
14. Corasaniti M.T., Russo R., Amantea D., Gliozzi M., Siviglia E., Stringaro A.R., Malori W., Melino G., and Bagetta G. Neuroprotection by the caspase-1 inhibitor Ac-YVAD-(acyloxy)mk in experimental neuroAIDS is independent from IL-1β generation. Cell Death Differ. 12 (2005) 999-1001
15. Cunningham L.A., Wetzel M., and Rosenberg G.A. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50 (2005) 329-339
16. Davies C.A., Loddick S.A., Toulmond S., Stroemer R.P., Hunt J., and Rothwell N.J. The progression and topographic distribution of interleukin-1 beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19 (1999) 87-98
17. Dubois B., Peumans W.J., Van Damme E.J., Van Damme J., and Opdenakker G. Regulation of gelatinase B (MMP-9) in leukocytes by plant lectins. FEBS Lett. 427 (1998) 275-278
18. Eriksson C., Van Dam A.-M., Lucassen P.J., Bol J.G.J., Winblad B., and Schultzberg M. Immunohistochemical localization of interleukin-1β, interleukin-1 receptor antagonist and interleukin-1β converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 93 (1999) 915-930
19. Fantuzzi G., Ku G., Harding M.W., Livingston D.J., Sipe J.D., Kuida K., Flavell R.A., and Dinarello C.A. Response to local inflammation of IL-1β-converting enzyme-deficient mice. J. Immunol. 158 (1997) 1818-1824
20. Friedlander R.M., and Yuan J. ICE, neuronal apoptosis and neurodegeneration. Cell Death Differ. 5 (1998) 823-831
21. Garcia J.H., Liu K.F., and Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147 (1995) 1477-1486
22. Garcia-Calvo M., Peterson E.P., Leiting B., Ruel R., Nicholson D.W., and Thornberry N.A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273 (1998) 32608-32613
23. Gasche Y., Copin J.C., Sugawara T., Fujimura M., and Chan P.H. Matrix metalloproteinase inhibition prevents oxidative stress associated blood-brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 21 (2001) 1393-1400
24. Goldberg G.I., Strongin A., Coolier I.E., Genrich L.T., and Marmer B.L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267 (1992) 4583-4591
25. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., and Lipton S.A. S-nitrosylation of matrix metalloproteinases: Signalling pathway to neuronal cell death. Science 297 (2002) 1186-1190
26. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., and Lipton S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25 (2005) 6401-6408
27. Hagan P., Poole S., Bristow A.F., Tilders F., and Silverstein F.S. Intracerebral NMDA injection stimulates production of interleukin-1β in perinatal rat brain. J. Neurochem. 67 (1996) 2215-2218
28. Hara H., Fink K., Endres M., Friedlander R.M., Gagliardini V., Yuan J., and Moskowitz M.A. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J. Cereb. Blood Flow Metab. 17 (1997) 370-375
29. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., and Moskowitz M.A. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94 (1997) 2007-2012
30. Heo J.H., Lucero J., Abumiya T., Koziol J.A., Copeland B.R., and del Zoppo G.J. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19 (1999) 624-633
31. Horstmann S., Kalb P., Koziol J., Gardner H., and Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: Influence of different therapies. Stroke 34 (2003) 2165-2170
32. Howard A.D., Kostura M.J., Thornberry N., Ding G.J.F., Limjuco G., Weidner J., Salley J.P., Hogquist K.A., Chaplin D.D., Mumford R.A., Schmidt J.A., and Tocci M.J. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1α. J. Immunol. 147 (1991) 2964-2969
33. Ito A., Mukaiyama A., Itoh Y., Nagase H., Thøgersen I.B., Enghild J.J., Sasaguri Y., and Mori Y. Degradation of interleukin 1β by matrix metalloproteinases. J. Biol. Chem. 271 (1996) 14657-14660
34. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A.M., Le Diguardjer T., Khrestchatisky M., and Rivera S. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur. J. Neurosci. 18 (2003) 1507-1517
35. Lee R., Kermani P., Teng K.K., and Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 294 (2001) 1945-1948
36. Legos J.J., Whitmore R.G., Erhardt J.A., Parsons A.A., Tuma R.F., and Barone F.C. Quantitative changes in interleukin proteins following focal stroke in the rat. Neurosci. Lett. 282 (2000) 189-192
37. Levy D.E., Lapierre F., Liang W., Ye Y., Lange C.W., Li X., Grobelny D., Casabonne M., Tyrrell D., Holme K., Nadzan A., and Galardy R.E. Matrix metalloproteinase inhibitors: A structure-activity study. J. Med. Chem. 41 (1998) 199-223
38. Li H., Colbourne F., Sun P., Zhao Z., Buchan A.M., and Iadecola C. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke 31 (2000) 176-182
39. Liu T., McDonnell P.C., Young P.R., White R.F., Siren A.L., Hallenbeck J.M., Barone F.C., and Feurerstein G.Z. Interleukin-1-beta messenger RNA expression in ischemic rat cortex. Stroke 24 (1993) 1746-1751
40. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 20 (1989) 84-91
41. Magnoni S., Baker A., George S.J., Duncan W.C., Kerr L.E., McCulloch J., and Horsburgh K. Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice. Neurobiol. Dis. 17 (2004) 188-197
42. Mulcahy N., Ross J., Rothwell N.J., and Loddick S.A. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischemia in the rat. Br. J. Pharmacol. 140 (2003) 471-476
43. O'Shea E., Sanchez V., Orio L., Escobedo I., Green A.R., and Colado M.I. 3,4-methylenedioxymethamphetamine increases prointerleukin-1β production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: Role of inteleukin-1β in neurotoxicity. Neuroscience 135 (2005) 1095-1105
44. Pagenstecher A., Stadler A.K., Kincaid C.L., Volk B., and Campbell I.L. Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccaride-induced endotoxemia in mice. Am. J. Pathol. 157 (2000) 197-210
45. Parks W.C., Wilson C.L., and Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4 (2004) 617-629
46. Planas A.M., Sole A., and Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol. Dis. 8 (2001) 834-846
47. Rabuffetti M., Sciorati C., Tarozzo G., Clementi E., Manfredi A.A., and Beltramo M. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-Chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J. Neurosci. 20 (2000) 4398-4404
48. Rano T.A., Timkey T., Peterson E.P., Rotonda J., Nicholson D.W., Becker J.W., Chapman K.T., and Thornberry N.A. A combinatorial approach for determining protease specificities: Application to interleukin-1beta converting enzyme (ICE). Chem. Biol. 4 (1997) 149-155
49. Relton J.K., and Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29 (1992) 242-246
50. Relton J.K., Martin D., Thompson R.C., and Russell D.A. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. 138 (1996) 206-213
51. Rivera S., Ogier C., Jourquin J., Timsit S., Szklarczyk A.W., Miller K., Gearing A.J.H., Kaczmarek L., and Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur. J. Neurosci. 15 (2002) 19-32
52. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., and Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-1030
53. Rosell A., Ortega-Aznar A., Alvarez-Sabin J., Fernandez-Cadenas I., Ribo M., Molina C.A., Lo E.H., and Montanter J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37 (2006) 1399-1406
54. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 (2002) 279-291
55. Rosenberg G.A., Navratil M., Barone F., and Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab. 16 (1996) 360-366
56. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
57. Rosenberg G.A., Cunningham L.A., Wallace J., Alexander S., Estrada E.Y., Grossetete M., Razhagi A., Miller K., and Gearing A. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: Activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893 (2001) 104-112
58. Rothwell N. Interleukin-1 and neuronal injury: Mechanisms, modification, and therapeutic potential. Brain Behav. Immun. 17 (2003) 152-157
59. Schielke G.P., Yang G.Y., Shivers B.D., and Lorris Betz A. Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18 (1998) 180-185
60. Schönbeck U., Mach F., and Libby P. Generation of biologically active IL-1β by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1β processing. J. Immunol. 161 (1998) 3340-3346
61. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behaviour. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
62. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., and Dixit V.M. Yama/CPP32 beta, a mammalian homolg of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81 (1995) 801-809
63. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., Elliston K.O., Ayala J.M., et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356 (1992) 768-774
64. Wang X.K., Yue T.L., Barone F.C., White R.F., Gagnon R.C., and Feuerstein G.Z. Concomitant cortical expression of TNF-α and IL-1β mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23 (1994) 103-114
65. Wetzel M., Rosenberg G.A., and Cunningham L.A. Tissue inhibitor of metalloproteinase-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur. J. Neurosci. 18 (2003) 1050-1060
66. Yamasaki Y., Matsuura N., Shizuhara H., Onodera H., and Itoyama Y.K.K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in the rats. Stroke 26 (1995) 676-681
67. Yang G.Y., Schielke G.P., Gong C., Mao Y., Ge H.L., Liu X.H., and Betz A.L. Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1β converting enzyme deficient mice. J. Cereb. Blood Flow Metab. 19 (1999) 1109-1117
68. Yong V.W. Metalloproteinases: Mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6 (2005) 931-944
69. Zhang Z., Chopp M., Goussev A., and Powers C. Cerebral vessels express interleukin 1 beta after focal cerebral ischemia. Brain Res. 784 (1998) 210-217
70. Zhang K., McQuibban G.A., Silva C., Butler G.S., Johnston J.B., Holden J., Clark-Lewis I., Overall C.M., and Power C. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat. Neurosci. 6 (2003) 1064-1071
71. Zhang W.H., Wang X., Narayanan M., Zhang Y., Huo C., Reed J.C., and Friedlander R.M. Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc. Natl. Acad. Sci. USA 100 (2003) 16012 7
72. Zhao B.-Q., Wang S., Kim H.-Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., and Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12 (2006) 441-445